比托皮性干支持在β2上腺素受体的基结合位的存在
Birgit Isabel Gaiser1, Mia Danielsen1, Xinyu Xu2
1Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, 2100 Copenhagen, Denmark.
Journal of medicinal chemistry
|July 2, 2024
概括
在药物设计中,转移稳定的结合位点 (MBS) 可以用作全结合位点 (ABS). 这一策略改善了连接体结合动力学,正如一种新的β-2上腺素受体 (β2AR) 连接体所证明的那样.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 计算化学计算化学
背景情况:
- 超稳定结合点 (MBS) 是在分子动力学模拟中观察到的低亲和度全结合点 (ABS).
- 这些部位作为中间体,促进联结体向 Orthosteric 结合部位 (OBS) 的进展.
研究的目的:
- 为了研究MBS作为ABS在连接体设计中的实用性,以改善结合动力学.
- 开发针对OBS和MBS同时使用的新型配体.
主要方法:
- 分子对接 (S) -阿尔诺醇 ((S) -ALP) 进入β-2上腺素受体 (β2AR) 晶体结构.
- 设计和合成四种同等价值的双联体 (1-4).
- 进行X射线结晶学以确认连接体结合模式.
主要成果:
- 连接物4表现出与 (S) -ALP.相似的强度和亲和力.
- 与 (S) -ALP.相比,连接剂4的停留时间增加了超过4倍.
- X射线结晶学证实了与β2AR.复合体中的联结体4的结合方式.
结论:
- 在连接体设计中,可有效地利用转移稳定的结合点作为全结合点.
- 这种方法增强了连接体结合动力学,特别是增加了停留时间.
- 该策略适用于超出β2AR和G蛋白结合受体 (GPCRs) 的范围,用于整体改善 ортостерик连接体药理学.
相关概念视频
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K


